chr16-88804608-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The ENST00000301019.9(CDT1):āc.292A>Gā(p.Ile98Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000768 in 1,612,900 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I98T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000301019.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDT1 | NM_030928.4 | c.292A>G | p.Ile98Val | missense_variant | 2/10 | ENST00000301019.9 | NP_112190.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDT1 | ENST00000301019.9 | c.292A>G | p.Ile98Val | missense_variant | 2/10 | 1 | NM_030928.4 | ENSP00000301019 | P1 | |
CDT1 | ENST00000562747.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00386 AC: 587AN: 152126Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00132 AC: 329AN: 249024Hom.: 0 AF XY: 0.000917 AC XY: 124AN XY: 135204
GnomAD4 exome AF: 0.000445 AC: 650AN: 1460656Hom.: 3 Cov.: 33 AF XY: 0.000403 AC XY: 293AN XY: 726602
GnomAD4 genome AF: 0.00387 AC: 589AN: 152244Hom.: 4 Cov.: 33 AF XY: 0.00404 AC XY: 301AN XY: 74422
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | CDT1: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 19, 2017 | - - |
CDT1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 14, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at